ArticlePloS one2010
Optimizing vaccine allocation at different points in time during an epidemic.
Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed.
- Article
- Analyzing greedy vaccine allocation algorithms for metapopulation disease models.PLoS computational biology · 2025Article
- Article
- Novel multi-cluster workflow system to support real-time HPC-enabled epidemic science: Investigating the impact of vaccine acceptance on COVID-19 spread.Journal of parallel and distributed computing · 2024Article
- Comparative performance of between-population vaccine allocation strategies with applications for emerging pandemics.Vaccine · 2023Article
- Sequential allocation of vaccine to control an infectious disease.Mathematical biosciences · 2022Article
- Multi-period vaccine allocation model in a pandemic: A case study of COVID-19 in Australia.Transportation research. Part E, Logistics and transportation review · 2022Article
- Optimizing one-dose and two-dose cholera vaccine allocation in outbreak settings: A modeling study.PLoS neglected tropical diseases · 2022Article
- How can age-based vaccine allocation strategies be optimized? A multi-objective optimization framework.Frontiers in public health · 2022Article
- Optimal allocation of limited vaccine to minimize the effective reproduction number.Mathematical biosciences · 2021Article
- Optimal allocation of limited vaccine to control an infectious disease: Simple analytical conditions.Mathematical biosciences · 2021Article
- Article
- Vaccine optimization for COVID-19: who to vaccinate first?medRxiv : the preprint server for health sciences · 2020Article
- Optimal Management of Public Perceptions During A Flu Outbreak: A Game-Theoretic Perspective.Bulletin of mathematical biology · 2020Article
- Vaccine optimization for COVID-19: Who to vaccinate first?Science advances · 2020Article
- Oligomerization of bacterially expressed H1N1 recombinant hemagglutinin contributes to protection against viral challenge.Scientific reports · 2018Article
- Dose-Optimal Vaccine Allocation over Multiple Populations.Production and operations management · 2018Article
- Value of inventory information in allocating a limited supply of influenza vaccine during a pandemic.PloS one · 2018Article
- Article
- Controlling infectious disease outbreaks: A deterministic allocation-scheduling model with multiple discrete resources.Journal of systems science and systems engineering · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundPandemic influenza A(H1N1) 2009 began spreading around the globe in April of 2009 and vaccination started in October of 2009. In most countries, by the time vaccination started, the second wave of pandemic H1N1 2009 was already under way. With limited supplies of vaccine, we are left to question whether it may be a good strategy to vaccinate the high-transmission groups earlier in the epidemic, but it might be a better use of resources to protect instead the high-risk groups later in the epidemic. To answer this question, we develop a deterministic epidemic model with two age-groups (children and adults) and further subdivide each age group in low and high risk. METHODS AND
findingsWe COMPARE optimal vaccination strategies started at various points in time in two different. SETTINGS: a population in a developed country where children account for 24% of the population, and a population in a less developed country where children make up the majority of the population, 55%. For each of these populations, we minimize mortality or hospitalizations and we find an optimal vaccination strategy that gives the best vaccine allocation given a starting vaccination time and vaccine coverage level. We find that population structure is an important factor in determining the optimal vaccine distribution. Moreover, the optimal policy is dynamic as there is a switch in the optimal vaccination strategy at some time point just before the peak of the epidemic. For instance, with 25% vaccine coverage, it is better to protect the high-transmission groups before this point, but it is optimal to protect the most vulnerable groups afterward.
conclusionsChoosing the optimal strategy before or early in the epidemic makes an important difference in minimizing the number of influenza infections, and consequently the number of influenza deaths or hospitalizations, but the optimal strategy makes little difference after the peak.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.